161 related articles for article (PubMed ID: 25470631)
1. Age and gender differences in the clustering of metabolic syndrome combinations: A prospective cohort research from the Kerman Coronary Artery Disease Risk Study (KERCADRS).
Yousefzadeh G; Sheikhvatan M
Diabetes Metab Syndr; 2015; 9(4):337-42. PubMed ID: 25470631
[TBL] [Abstract][Full Text] [Related]
2. Prognostic interactions between cardiovascular risk factors.
Vishram JK
Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126
[TBL] [Abstract][Full Text] [Related]
3. Comparisons of different metabolic syndrome definitions and associations with coronary heart disease, stroke, and peripheral arterial disease in a rural Chinese population.
Wen J; Yang J; Shi Y; Liang Y; Wang F; Duan X; Lu X; Tao Q; Lu X; Tian Y; Wang N
PLoS One; 2015; 10(5):e0126832. PubMed ID: 25961739
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria.
Li WJ; Xue H; Sun K; Song XD; Wang YB; Zhen YS; Han YF; Hui RT
Chin Med J (Engl); 2008 Aug; 121(16):1532-6. PubMed ID: 18985935
[TBL] [Abstract][Full Text] [Related]
5. Comparison of coronary heart disease risk among four diagnostic definitions of metabolic syndrome.
Suzuki T; Zeng Z; Zhao B; Wei Z; Tanabe M; Shimbo T; Kajio H; Kato N; Naruse M
J Endocrinol Invest; 2016 Nov; 39(11):1337-1346. PubMed ID: 27572249
[TBL] [Abstract][Full Text] [Related]
6. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects--a population-based study comparing three different definitions.
Nilsson PM; Engström G; Hedblad B
Diabet Med; 2007 May; 24(5):464-72. PubMed ID: 17381496
[TBL] [Abstract][Full Text] [Related]
7. The reliability of the National Cholesterol Education Program's Adult Treatment Panel III (NCEP/ATP III) and the International Diabetes Federation (IDF) definitions in diagnosing metabolic syndrome (MetS) among Gaza Strip Palestinians.
Sirdah MM; Abu Ghali AS; Al Laham NA
Diabetes Metab Syndr; 2012; 6(1):4-8. PubMed ID: 23014247
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of metabolic syndrome defined by the International Diabetes Federation and National Cholesterol Education Program criteria among Thai adults.
Aekplakorn W; Chongsuvivatwong V; Tatsanavivat P; Suriyawongpaisal P
Asia Pac J Public Health; 2011 Sep; 23(5):792-800. PubMed ID: 21984495
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of metabolic syndrome in Amol and Zahedan, Iran: a population based study.
Ostovaneh MR; Zamani F; Sharafkhah M; Ansari-Moghaddam A; Akhavan Khaleghi N; Saeedian FS; Rohani Z; Motamed N; Maadi M; Malekzadeh R; Poustchi H
Arch Iran Med; 2014 Jul; 17(7):477-82. PubMed ID: 24979559
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome and all-cause mortality in older men and women.
Forti P; Pirazzoli GL; Maltoni B; Bianchi G; Magalotti D; Muscari A; Mariani E; Ravaglia G; Zoli M
Eur J Clin Invest; 2012 Sep; 42(9):1000-9. PubMed ID: 22591032
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of metabolic syndrome according to different definitions in a hypertensive population.
Lioudaki E; Vrentzos GE; Mavrogeni H; Zeniodi MH; Ganotakis ES; Mikhailidis DP; Papadakis JA
Angiology; 2012 Jan; 63(1):39-47. PubMed ID: 21555311
[TBL] [Abstract][Full Text] [Related]
12. Association of cardiovascular risk factors in hypertensive subjects with metabolic syndrome defined by three different definitions.
Shrestha R; Jha SC; Khanal M; Gyawali P; Yadav BK; Jha B
JNMA J Nepal Med Assoc; 2011; 51(184):157-63. PubMed ID: 22922894
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome and nonalcoholic fatty liver disease in a Spanish population: influence of the diagnostic criteria used.
Caballería L; Pera G; Rodríguez L; Auladell MA; Bernad J; Canut S; Torán P
Eur J Gastroenterol Hepatol; 2012 Sep; 24(9):1007-11. PubMed ID: 22668875
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
[TBL] [Abstract][Full Text] [Related]
15. Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study.
Saltevo J; Vanhala M; Kautiainen H; Kumpusalo E; Laakso M
Diabet Med; 2008 Jun; 25(6):747-50. PubMed ID: 18435780
[TBL] [Abstract][Full Text] [Related]
16. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population.
Athyros VG; Ganotakis ES; Tziomalos K; Papageorgiou AA; Anagnostis P; Griva T; Kargiotis K; Mitsiou EK; Karagiannis A; Mikhailidis DP
Curr Med Res Opin; 2010 Mar; 26(3):713-9. PubMed ID: 20078335
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of different definitions of metabolic syndrome in predicting cardiovascular events in a cohort of non-diabetic Tehranian adults.
Hosseinpanah F; Asghari G; Barzin M; Golkashani HA; Azizi F
Int J Cardiol; 2013 Sep; 168(1):369-74. PubMed ID: 23041003
[TBL] [Abstract][Full Text] [Related]
18. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome.
Cussons AJ; Watts GF; Burke V; Shaw JE; Zimmet PZ; Stuckey BG
Hum Reprod; 2008 Oct; 23(10):2352-8. PubMed ID: 18635531
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of metabolic syndrome in pre- and postmenopausal Iranian women.
Maharlouei N; Bellissimo N; Ahmadi SM; Lankarani KB
Climacteric; 2013 Oct; 16(5):561-7. PubMed ID: 23157491
[TBL] [Abstract][Full Text] [Related]
20. Hyperuricemia and metabolic syndrome: lessons from a large cohort from Israel.
Cohen E; Krause I; Fraser A; Goldberg E; Garty M
Isr Med Assoc J; 2012 Nov; 14(11):676-80. PubMed ID: 23240372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
